Liquidia to Present at the 19th Annual Needham Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., April 09, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc.(Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT technology, today announced that Neal Fowler, Chief Executive Officer of Liquidia, will present a company overview virtually at the 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 9:20am Eastern time.

Metadata
Provider: 
GlobeNewswire, Inc.GlobeNewswire, Inc.
Retrieved on: 
Thursday, April 9, 2020
Information
Tags: 
Galmed Pharmaceuticals Ltd., Companies, Pharmaceutical companies, Two River
Geotags: 
Morrisville, NC, Us
Organisation: 
LIQUIDIA TECHNOLOGIES, INC.
Summary
Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., April 09, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc.(Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT technology, today announced that Neal Fowler, Chief Executive Officer of Liquidia, will present a company overview virtually at the 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 9:20am Eastern time.
  • A link to the live audio webcast and replay of the presentation will be available on the Events & Presentations page of the Companys corporate website, and will be archived for a minimum of 90 days.
  • Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT technology to transform the lives of patients.
  • Liquidia is headquartered in Research Triangle Park, NC.


RESEARCH TRIANGLE PARK, N.C., April 09, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, today announced that Neal Fowler, Chief Executive Officer of Liquidia, will present a company overview virtually at the 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 9:20am Eastern time.

A link to the live audio webcast and replay of the presentation will be available on the Events & Presentations page of the Company’s corporate website, and will be archived for a minimum of 90 days.

About Liquidia

Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC. For more information, please visit www.liquidia.com.

Contact Information

Investor Relations:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
[email protected]

Primary Logo
Copyright: 
2020 GlobeNewswire, Inc.. All Rights Reserved.